Literature DB >> 2373511

Quantitative dermatoglyphics in schizophrenia: study of family history subgroups.

L Fañanás1, P Moral, J Bertranpetit.   

Abstract

Finger and a-b palmar ridge-count dermatoglyphic features were studied in schizophrenics with and without a positive family history of schizophrenia. Associations are reported for low quantitative dermatoglyphic values in schizophrenia. The differences found between the two subgroups of patients support the genetic heterogeneity of schizophrenia and stress the existence of congenital factors when there is no family history, that is, a genetic background.

Entities:  

Mesh:

Year:  1990        PMID: 2373511

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  5 in total

Review 1.  Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?

Authors:  Michael T Compton; Elaine F Walker
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

Review 2.  The presentation of dermatoglyphic abnormalities in schizophrenia: a meta-analytic review.

Authors:  Shana Golembo-Smith; Deborah J Walder; Maureen P Daly; Vijay A Mittal; Emily Kline; Gloria Reeves; Jason Schiffman
Journal:  Schizophr Res       Date:  2012-10-29       Impact factor: 4.939

3.  Dermatoglyphic profile in 22q deletion syndrome.

Authors:  B Martín; L Fañanás; B Gutiérrez; E W C Chow; A S Bassett
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-07-01       Impact factor: 3.568

4.  A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors.

Authors:  E Bramon; R M Murray
Journal:  Dialogues Clin Neurosci       Date:  2001-12       Impact factor: 5.986

5.  Directional and fluctuating asymmetry in finger and a-b ridge counts in psychosis: a case-control study.

Authors:  Sukanta Saha; Danuta Loesch; David Chant; Joy Welham; Ossama El-Saadi; Lourdes Fañanás; Bryan Mowry; John McGrath
Journal:  BMC Psychiatry       Date:  2003-03-23       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.